Why Dr. Martens’ IPO Makes Perfect Sense
Few footwear brands can rival Dr. Martens when it comes to its influence on subcultures across the globe. From the rebellious punks of the ‘70s and ‘80s, to the grungers of the ‘90s and indie kids of the noughties, the label remains a paradigmatic visualisation of countless eras. Renowned for its unique air-cushioned soles, welted construction and contrasting yellow stitching, the British footwear label remains as popular as ever, seen on the daily across the streets of Europe. According to the BBC, the label sells on average around 11 million pairs of shoes a year, with annual sales of £672m – and is one of few brands to buck the impact that the Coronavirus pandemic has had on countless brands. In fact, Dr. Martens’ revenues for the six months leading to September 2020 were up by 18-percent on the previous year at £318.2m. Read more at Hypebeast.
